Latest Research & Analysis

25-Feb-2021 - As of the date of the response in the table below, we received Freedom of Information Act (FOIA) responses from the SEC to suggest the absence of recent SEC investigative activity.  If you think any of these companies have SEC investigations, or had them in the recent past, let...

28-Jan-2021 - As of the date of the response in the table below, we received Freedom of Information Act (FOIA) responses from the SEC to suggest the absence of recent SEC investigative activity.  If you think any of these companies have SEC investigations, or had them in the recent past, let...

27-Jan-2021 - Today’s research reports -- AT&T, Inc. – T Carvana Co. – CVNA Computer Task Group Inc. – CTG Myriad Genetics, Inc. – MYGN Nektar Therapeutics – NKTR ResMed, Inc. – RMD Salesforce.com, Inc. – CRM SEI Investments Co. – SEIC Synchronoss Technologies, Inc. – SNCR...

27-Jan-2021 - AT&T, Inc. – T:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the Freedom...

27-Jan-2021 - Computer Task Group Inc. – CTG:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

27-Jan-2021 - Myriad Genetics, Inc. – MYGN:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

27-Jan-2021 - Nektar Therapeutics – NKTR:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the...

27-Jan-2021 - ResMed, Inc. – RMD:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the Freedom...

Pages